Literature DB >> 16373999

Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes.

Ralf Schindler1, Thomas Ertl, Werner Beck, Julia Lepenies, Olaf Boenisch, Martin Oppermann, Eva Kaspar, Ulrich Frei.   

Abstract

The increasing use of high-flux membranes for hemodialysis (HD) has raised concerns that these membranes may confer a higher risk of exposure to cytokine-inducing, bacterial substances (CIS) in the dialysate. Several studies, however, reported higher transfer of CIS through low-flux cellulosic than high-flux synthetic membranes. This surprising paradox was explained by adsorption of CIS to certain high-flux membranes. In order to investigate flux and membrane type independently, we studied two synthetic Polyflux (PF) membranes of the same type but with different flux properties and compared them to a cellulosic membrane (Cuprophan). Three different approaches were employed: (1) cytokine induction in whole blood during in vitro HD contaminated with bacterial filtrates, (2) removal of recombinant C5a, and (3) transfer of purified lipopolysaccharide (LPS). After 90 min recirculation of whole blood, the appearance of IL-6-inducing substances on the blood side was lowest with high-flux PF (1.1 +/- 0.2 ng/ml), slightly higher with low-flux PF (1.9 +/- 0.7 ng/ml) and highest with Cuprophan (4.1 +/- 1 ng/ml). Recombinant C5a added to plasma on the blood side was markedly removed by high-flux PF (by 83%), to a lesser degree and only in the presence of ultrafiltration with low-flux PF (by 54%) and not significantly with Cuprophan (by 11%). Significant transfer of purified LPS from the dialysate onto the blood side was only observed with the cellulosic membrane. We conclude that in contrast to cellulosic membranes, certain synthetic membranes do not permit transfer of LPS. Cytokine induction on the blood side is further reduced by the use of high-flux membranes due to removal of activated complement factors. (c) 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373999     DOI: 10.1159/000090520

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

Review 1.  Home haemodialysis and uraemic toxin removal: does a happy marriage exist?

Authors:  Raymond Vanholder; Sunny Eloot; Nathalie Neirynck; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

2.  Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.

Authors:  Eva Schepers; Griet Glorieux; Sunny Eloot; Michael Hulko; Adriana Boschetti-de-Fierro; Werner Beck; Bernd Krause; Wim Van Biesen
Journal:  BMC Nephrol       Date:  2018-01-05       Impact factor: 2.388

3.  Performance of hemodialysis with novel medium cut-off dialyzers.

Authors:  Alexander H Kirsch; Raphael Lyko; Lars-Göran Nilsson; Werner Beck; Michael Amdahl; Petra Lechner; Andreas Schneider; Christoph Wanner; Alexander R Rosenkranz; Detlef H Krieter
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

4.  Pyrogen retention: Comparison of the novel medium cut-off (MCO) membrane with other dialyser membranes.

Authors:  Michael Hulko; Verena Dietrich; Ilona Koch; Alexander Gekeler; Michael Gebert; Werner Beck; Bernd Krause
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

5.  Haemodiafiltration-optimal efficiency and safety.

Authors:  Ingrid Ledebo; Peter J Blankestijn
Journal:  NDT Plus       Date:  2009-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.